Skip to content
healthcare.dev

Amlodipine Besylate

NDC 70518-2632, Amlodipine besylate, tablet, from REMEDYREPACK INC..

Product NDC
70518-2632
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078925
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2632 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BESYLATE10 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

Package NDCNDC-11Package
70518-2632-07051826320030 TABLET in 1 BLISTER PACK (70518-2632-0)
70518-2632-57051826320530 TABLET in 1 BLISTER PACK (70518-2632-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/58a67272-c4c7-4e2c-85a5-9d39034d12c3

Use it

Look up 70518-2632 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2632 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-2632. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.